Van Heesch team finds hundreds of unknown mini-proteins in failing hearts
Updated
Updated · STAT · May 6
Van Heesch team finds hundreds of unknown mini-proteins in failing hearts
2 articles · Updated · STAT · May 6
Using ribosome profiling on frozen hearts donated by 80 people, many of whom died from end-stage heart failure, the researchers detected previously unseen protein production.
Many of the short “dark proteins” appeared to originate from genome regions long considered noncoding and were often targeted to mitochondria, suggesting possible effects on cardiac energy production.
The findings open a new window on hidden biology in heart failure, revealing translation activity that conventional gene maps had missed and raising fresh questions about disease mechanisms.
Scientists found a new class of molecules called 'peptideins'. Can they be targeted to reverse damage in failing human hearts?
The human genome has a secret second code. What will this new layer of biology teach us about treating disease?
Mapping the Human Heart’s Microproteome: Discovery of 100+ Mitochondrial Microproteins Driving Cardiac Energy and Disease
Overview
A landmark 2026 study using advanced ribosome profiling revealed that the human heart produces hundreds of previously unknown microproteins, many targeted to mitochondria, adding a new layer to cardiac energy regulation. These microproteins play vital roles in mitochondrial function, calcium handling, and energy metabolism, influencing heart failure development. Importantly, many microproteins are unique to humans, highlighting the need for direct human tissue research. This discovery opens new avenues for early diagnosis and targeted therapies for heart diseases like dilated cardiomyopathy, though challenges remain in validating biomarkers and delivering treatments effectively. Future research will enhance detection methods and integrate multi-omics data to better understand these tiny but crucial proteins.